News & Updates

Show Multimedia Only

Add-on clomiphene citrate benefits women with anovulation, PCOS

22 Jul 2025 by

Adding clomiphene citrate (CC) to letrozole improves ovulation as opposed to letrozole alone in women with polycystic ovarian syndrome (PCOS) or anovulatory infertility, findings from a study suggest.

Add-on clomiphene citrate benefits women with anovulation, PCOS

22 Jul 2025

Gestational hypertension may be linked to cerebral small vessel disease

21 Jul 2025

Midlife women with a history of gestational hypertension exhibit some signs of cerebral small vessel disease, according to a study.

Gestational hypertension may be linked to cerebral small vessel disease

21 Jul 2025

Oral, transdermal hormone therapies equally preserve bone health in premature ovarian insufficiency

13 Jul 2025

Hormone therapy, whether administered orally or applied transdermally, helps maintain bone mineral density in women with premature ovarian insufficiency, according to a single-centre retrospective study.

Oral, transdermal hormone therapies equally preserve bone health in premature ovarian insufficiency

13 Jul 2025

Pembrolizumab + CCRT ups survival in high-risk LACC

10 Jul 2025 by

Treatment with the combination of pembrolizumab and concurrent chemoradiotherapy (CCRT), followed by pembrolizumab maintenance, led to a sustained, long-term survival benefit in patients with high-risk, locally advanced cervical cancer (LACC) compared with CCRT alone, according to the final analysis of the phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial presented at ASCO 2025.

Pembrolizumab + CCRT ups survival in high-risk LACC

10 Jul 2025

Hormone therapy's impact on young-onset breast cancer risk varies by type

06 Jul 2025

New research shows that using oestrogen hormone therapy alone may reduce the risk of young-onset breast cancer, while combining it with progestin could result in a risk increase among women with intact uterus and ovaries.

Hormone therapy's impact on young-onset breast cancer risk varies by type

06 Jul 2025

DESTINY-Breast09: T-DXd plus pertuzumab improves PFS in HER2+ breast cancer

05 Jul 2025 by

Treatment with trastuzumab deruxtecan (T-DXd) plus pertuzumab significantly improved progression-free survival (PFS) in patients with HER2+ advanced/metastatic breast cancer (a/mBC) compared with standard of care in the first-line setting, according to a planned interim analysis of the phase III DESTINY-Breast09 trial presented at ASCO 2025.

DESTINY-Breast09: T-DXd plus pertuzumab improves PFS in HER2+ breast cancer

05 Jul 2025

Flu shot during pregnancy extends protection to offspring

02 Jul 2025

Influenza vaccination in pregnant women, especially during the second or third trimester, cuts the risk of infection in infants, as shown in a study.

Flu shot during pregnancy extends protection to offspring

02 Jul 2025

Two-drug combo rises to the challenge as 1L Tx for mTNBC

02 Jul 2025 by

In the primary analysis of the ASCENT-04/KEYNOTE-D19 study, a combination regimen comprising sacituzumab govitecan (SG) and pembrolizumab delivers significant progression-free survival (PFS) benefit in women with previously untreated PD-L1+ advanced triple-negative breast cancer (TNBC).

Two-drug combo rises to the challenge as 1L Tx for mTNBC

02 Jul 2025

Adjuvant pertuzumab delivers survival gain in HER2+ EBC

01 Jul 2025 by

The APHINITY trial of adding pertuzumab to adjuvant therapy for early HER2+ breast cancer turns in a significant OS improvement, with results presented at ESMO Breast Cancer 2025 concluding a phase III trial spanning over a decade

Adjuvant pertuzumab delivers survival gain in HER2+ EBC

01 Jul 2025

Music therapy provides valuable support in gynaecologic cancer patients in palliative care in SG

28 Jun 2025 by

For women with gynaecologic cancer undergoing inpatient palliative care in Singapore, music therapy helps create a comfortable space to disengage from difficult realities, celebrate life, and process grief and other challenging emotions, as shown in a qualitative study.

Music therapy provides valuable support in gynaecologic cancer patients in palliative care in SG

28 Jun 2025

News & Updates

Filter by Specialty:

Specialty:

Add-on clomiphene citrate benefits women with anovulation, PCOS

Add-on clomiphene citrate benefits women with anovulation, PCOS

Gestational hypertension may be linked to cerebral small vessel disease

Gestational hypertension may be linked to cerebral small vessel disease

Oral, transdermal hormone therapies equally preserve bone health in premature ovarian insufficiency

Oral, transdermal hormone therapies equally preserve bone health in premature ovarian insufficiency

Pembrolizumab + CCRT ups survival in high-risk LACC

Pembrolizumab + CCRT ups survival in high-risk LACC

Hormone therapy's impact on young-onset breast cancer risk varies by type

Hormone therapy's impact on young-onset breast cancer risk varies by type

DESTINY-Breast09: T-DXd plus pertuzumab improves PFS in HER2+ breast cancer

DESTINY-Breast09: T-DXd plus pertuzumab improves PFS in HER2+ breast cancer

Flu shot during pregnancy extends protection to offspring

Flu shot during pregnancy extends protection to offspring

Two-drug combo rises to the challenge as 1L Tx for mTNBC

Two-drug combo rises to the challenge as 1L Tx for mTNBC

Adjuvant pertuzumab delivers survival gain in HER2+ EBC

Adjuvant pertuzumab delivers survival gain in HER2+ EBC

Music therapy provides valuable support in gynaecologic cancer patients in palliative care in SG

Music therapy provides valuable support in gynaecologic cancer patients in palliative care in SG